https://aliquantumrx.com/discovery-of-novel-liver-stage-antimalarials-through-quantum-similarity/2020-02-14T11:50:20-08:00https://aliquantumrx.com/quantum-biosciences-llc-launches-to-develop-cethromycin-as-a-new-malaria-drug/2020-02-14T11:51:04-08:00https://aliquantumrx.com/example-3/2020-02-14T11:48:35-08:00https://aliquantumrx.com/example-4/2020-02-14T11:49:46-08:00https://aliquantumrx.com/macrolide-compounds-and-their-use-in-liver-stage-malaria-and-related-disease/2020-02-14T11:51:30-08:00https://aliquantumrx.com/tedco-maryland-innovation-initiative-mii-award/2020-02-14T11:51:59-08:00https://aliquantumrx.com/ncats-r21-grant/2020-02-14T11:52:55-08:00https://aliquantumrx.com/quantum-biosciences-llc-restructures-and-re-brands-as-aliquantumrx-inc/2020-02-14T11:53:27-08:00https://aliquantumrx.com/macrolide-compounds-and-their-use-in-liver-stage-malaria-and-related-disease-2/2020-02-14T11:53:50-08:00https://aliquantumrx.com/aliquantumrx-inc-signs-a-licensing-agreement-with-johns-hopkins-technology-ventures/2020-02-14T11:54:19-08:00https://aliquantumrx.com/aliquantumrx-inc-raises-500000-from-angel-investors/2020-02-14T11:54:46-08:00https://aliquantumrx.com/new-patent-salts-and-polymorphs-of-cethromycin-for-the-treatment-of-disease/2020-02-14T11:55:02-08:00https://aliquantumrx.com/2020-aliquantumrx-receives-tedco-funding/2020-07-27T08:31:40-07:00https://aliquantumrx.com/salts-and-polymorphs-of-cethromycin-for-the-treatment-of-disease/2022-11-07T20:25:33-08:00https://aliquantumrx.com/patent-cooperation-treaty-application/2022-11-07T20:33:37-08:00https://aliquantumrx.com/clinical-trial-success-story/2022-11-07T20:35:56-08:00https://aliquantumrx.com/patent-cooperation-treaty-national-phase/2022-11-07T20:39:27-08:00https://aliquantumrx.com/cdmrp-grant/2022-11-07T20:41:31-08:00https://aliquantumrx.com/may-27-2023-uspto-approves-aliquantumrx-inc-s-patent-salts-and-polymorphs-of-cethromycin-for-the-treatment-of-bacterial-and-protozoan-disease/2025-05-29T07:12:02-07:00https://aliquantumrx.com/the-united-states-army-medical-research-institute-of-infectious-diseases-completes-in-vitro-studies-for-the-antimicrobial-activity-of-cethromycin-hcl-against-bacterial-biothreat-pathogens/2025-04-29T01:52:27-07:00https://aliquantumrx.com/aliquantumrx-inc-signs-a-material-and-transfer-agreement-with-the-university-of-georgia/2025-04-29T01:51:24-07:00https://aliquantumrx.com/aliquantumrx-inc-signs-a-cooperative-research-and-development-agreement-with-the-united-states-army-medical-research-institute-of-infectious-diseases-usamriid/2025-04-29T01:44:58-07:00https://aliquantumrx.com/china-peoples-republic-approves-aliquantumrx-inc-s-patent-salts-and-polymorphs-of-cethromycin-for-the-treatment-of-bacterial-and-protozoan-disease/2025-06-11T05:45:03-07:00https://aliquantumrx.com/aliquantumrx-inc-s-patent-salts-and-polymorphs-of-cethromycin-for-the-treatment-of-bacterial-and-protozoan-disease-approved-in-japan/2025-07-16T08:35:15-07:00https://aliquantumrx.com/aliquantumrx-inc-granted-type-b-pre-ind-meeting-with-u-s-food-and-drug-administration-for-cethromycin-hcl-malaria-program/2026-01-23T21:11:11-08:00https://aliquantumrx.com/aliquantumrx-inc-announces-new-research-collaboration-and-development-agreement-with-johns-hopkins-university-to-advance-cethromycin-hcl-for-liver-stage-malaria/2026-01-23T21:10:52-08:00https://aliquantumrx.com/fda-clears-path-to-clinic-without-additional-ind-enabling-toxicology-studies/2026-04-14T08:37:27-07:00